IGC Pharma annual return on assets (roa)
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
IGC Pharma Return on Assets (ROA) Growth & History (IGC)
IGC Pharma's return on assets (roa) was −44.92% for fiscal 2025.
View full IGC Pharma company overviewIGC Pharma annual return on assets (roa) history
| Fiscal year | Period ended | Return on assets (ROA) | Change (percentage points) |
|---|---|---|---|
| 2025 · Dec 31 | 2025-12-31 | −44.92% | — |
| 2025 · Mar 31 | 2025-03-31 | −76.38% | +19.63 pp |
| 2024 | 2024-03-31 | −96.01% | −43.73 pp |
| 2023 | 2023-03-31 | −52.29% | −4.39 pp |
| 2022 | 2022-03-31 | −47.90% | −20.72 pp |
| 2021 | 2021-03-31 | −27.17% | −4.12 pp |
| 2020 | 2020-03-31 | −23.06% | −4.98 pp |
| 2019 | 2019-03-31 | −18.08% | −1.95 pp |
| 2018 | 2018-03-31 | −16.14% | −3.75 pp |
| 2017 | 2017-03-31 | −12.39% | +1.94 pp |
| 2016 | 2016-03-31 | −14.33% | +9.91 pp |
| 2015 | 2015-03-31 | −24.24% | −7.90 pp |
| 2014 | 2014-03-31 | −16.34% | −6.22 pp |
| 2013 | 2013-03-31 | −10.12% | +25.58 pp |
| 2012 | 2012-03-31 | −35.70% | — |
IGC Pharma quarterly return on assets (roa)
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on assets (ROA) | Change (percentage points) |
|---|---|---|---|
| Q2 2026 · Jun 30 | 2026-06-30 | −76.69% | −8.25 pp |
| Q1 2026 · Mar 31 | 2026-03-31 | −59.67% | +16.71 pp |
| Q4 2025 · Dec 31 | 2025-12-31 | −44.13% | +42.50 pp |
| Q2 2026 · Sep 30 | 2025-09-30 | −64.11% | +29.43 pp |
| Q1 2026 · Jun 30 | 2025-06-30 | −68.44% | +32.85 pp |
| Q4 2025 · Mar 31 | 2025-03-31 | −76.38% | +19.63 pp |
| Q3 2025 | 2024-12-31 | −86.63% | +3.67 pp |
| Q2 2025 | 2024-09-30 | −93.54% | −37.35 pp |
| Q1 2025 | 2024-06-30 | −101.29% | −47.09 pp |
| Q4 2024 | 2024-03-31 | −96.01% | −43.73 pp |
| Q3 2024 | 2023-12-31 | −90.30% | −35.86 pp |
| Q2 2024 | 2023-09-30 | −56.18% | −5.60 pp |
| Q1 2024 | 2023-06-30 | −54.20% | +0.44 pp |
| Q4 2023 | 2023-03-31 | −52.29% | −4.39 pp |
| Q3 2023 | 2022-12-31 | −54.44% | −13.10 pp |
| Q2 2023 | 2022-09-30 | −50.58% | −12.68 pp |
| Q1 2023 | 2022-06-30 | −54.64% | −26.86 pp |
| Q4 2022 | 2022-03-31 | −47.90% | −20.72 pp |
| Q3 2022 | 2021-12-31 | −41.34% | −8.71 pp |
| Q2 2022 | 2021-09-30 | −37.90% | −9.89 pp |
| Q1 2022 | 2021-06-30 | −27.79% | −2.49 pp |
| Q4 2021 | 2021-03-31 | −27.17% | −4.12 pp |
| Q3 2021 | 2020-12-31 | −32.63% | −15.81 pp |
| Q2 2021 | 2020-09-30 | −28.01% | −6.63 pp |
| Q1 2021 | 2020-06-30 | −25.30% | −3.25 pp |
| Q4 2020 | 2020-03-31 | −23.06% | −4.98 pp |
| Q3 2020 | 2019-12-31 | −16.81% | −4.29 pp |
| Q2 2020 | 2019-09-30 | −21.38% | −3.14 pp |
| Q1 2020 | 2019-06-30 | −22.05% | −4.24 pp |
| Q4 2019 | 2019-03-31 | −18.08% | −1.95 pp |
| Q3 2019 | 2018-12-31 | −12.52% | +5.76 pp |
| Q2 2019 | 2018-09-30 | −18.24% | −6.90 pp |
| Q1 2019 | 2018-06-30 | −17.81% | −4.09 pp |
| Q4 2018 | 2018-03-31 | −16.14% | −3.75 pp |
| Q3 2018 | 2017-12-31 | −18.28% | −1.52 pp |
| Q2 2018 | 2017-09-30 | −11.34% | +3.36 pp |
| Q1 2018 | 2017-06-30 | −13.72% | +0.66 pp |
| Q4 2017 | 2017-03-31 | −12.39% | +1.94 pp |
| Q3 2017 | 2016-12-31 | −16.76% | +0.11 pp |
| Q2 2017 | 2016-09-30 | −14.70% | +2.95 pp |
| Q1 2017 | 2016-06-30 | −14.38% | +3.61 pp |
| Q4 2016 | 2016-03-31 | −14.33% | +9.91 pp |
| Q3 2016 | 2015-12-31 | −16.87% | +4.14 pp |
| Q2 2016 | 2015-09-30 | −17.65% | +1.79 pp |
| Q1 2016 | 2015-06-30 | −17.99% | −0.12 pp |
| Q4 2015 | 2015-03-31 | −24.24% | −7.90 pp |
| Q3 2015 | 2014-12-31 | −21.00% | −3.59 pp |
| Q2 2015 | 2014-09-30 | −19.44% | −6.21 pp |
| Q1 2015 | 2014-06-30 | −17.87% | −7.01 pp |
| Q4 2014 | 2014-03-31 | −16.34% | −6.22 pp |
| Q3 2014 | 2013-12-31 | −17.42% | −1.32 pp |
| Q2 2014 | 2013-09-30 | −13.24% | +20.32 pp |
| Q1 2014 | 2013-06-30 | −10.86% | +24.17 pp |
| Q4 2013 | 2013-03-31 | −10.12% | +25.58 pp |
| Q3 2013 | 2012-12-31 | −16.10% | — |
| Q2 2013 | 2012-09-30 | −33.56% | — |
| Q1 2013 | 2012-06-30 | −35.03% | — |
| Q4 2012 | 2012-03-31 | −35.70% | — |
IGC Pharma return on assets (roa) trends
Between the periods ended 2012-03-31 and 2025-12-31, IGC Pharma's return on assets (roa) decreased from −35.70% to −44.92%, a change of −9.22 percentage points. The latest reported quarter, Q2 2026 · Jun 30, shows −76.69%.
About the metric
What return on assets means
Return on assets measures profit relative to the assets used to generate it. It can help compare operating efficiency over time, although normal ROA differs substantially between asset-light and asset-intensive industries.
Calculation and source
How return on assets is calculated
TickerStat calculates annual ROA as reported net income divided by average total assets. Quarterly observations use trailing-12-month net income and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review IGC Pharma source filings ↗